Literature DB >> 16040010

Glutamate induces the expression and release of tumor necrosis factor-alpha in cultured hypothalamic cells.

Alok De1, James M Krueger, Steven M Simasko.   

Abstract

Tumor necrosis factor-alpha (TNFalpha) affects several CNS functions such as regulation of sleep, body temperature, and feeding during pathology. There is also evidence for TNFalpha involvement in physiological sleep regulation, e.g., TNFalpha induces sleep and brain levels of TNFalpha increase during prolonged wakefulness. The immediate cause of enhanced TNFalpha production in brain is unknown. We investigated whether glutamate could signal TNFalpha production because glutamate is a neurotransmitter associated with cell activation and wakefulness. We used primary cultures of fetal rat hypothalamic cells to examine the expression and release of TNFalpha. Immunostaining for neuron specific enolase revealed that the cultures were 50-60% neuronal and 40-50% non-neuronal cells. TNFalpha was detected in both the media and cells under basal conditions. Stimulation of the cells with 1 mM glutamate for 2 h produced an increase in media content of TNFalpha, whereas cell content was elevated at earlier time points. Using trypan blue exclusion and MTT assays, there was no evidence of cell toxicity with this stimulation protocol. Immunocytochemical staining revealed that TNFalpha was expressed by approximately 25% of the neurons and approximately 75% of the glial cell in the culture. Stimulation of the cultures with glutamate did not increase the percentage of cells expressing TNFalpha. We conclude that TNFalpha is constitutively expressed and released by healthy cultures of hypothalamic cells and that activation of the cells with a non-toxic challenge of glutamate increases TNFalpha production. These findings support the hypothesis that TNFalpha can participate in normal physiological regulation of sleep and feeding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040010     DOI: 10.1016/j.brainres.2005.06.044

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Chronic variable stress alters inflammatory and cholinergic parameters in hippocampus of rats.

Authors:  Bárbara Tagliari; Ana Paula Tagliari; Felipe Schmitz; Aline A da Cunha; Carla Dalmaz; Angela T S Wyse
Journal:  Neurochem Res       Date:  2010-12-24       Impact factor: 3.996

2.  SLEEP AND CYTOKINES.

Authors:  James M Krueger; David M Rector; Lynn Churchill
Journal:  Sleep Med Clin       Date:  2007

3.  Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.

Authors:  Edward Tobinick
Journal:  Medscape J Med       Date:  2008-06-10

4.  TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study.

Authors:  Edward Tobinick; Hyman Gross; Alan Weinberger; Hart Cohen
Journal:  MedGenMed       Date:  2006-04-26

Review 5.  Sleep as a fundamental property of neuronal assemblies.

Authors:  James M Krueger; David M Rector; Sandip Roy; Hans P A Van Dongen; Gregory Belenky; Jaak Panksepp
Journal:  Nat Rev Neurosci       Date:  2008-11-05       Impact factor: 34.870

6.  Tumor necrosis factor alpha: activity dependent expression and promotion of cortical column sleep in rats.

Authors:  L Churchill; D M Rector; K Yasuda; C Fix; M J Rojas; T Yasuda; J M Krueger
Journal:  Neuroscience       Date:  2008-07-18       Impact factor: 3.590

7.  Cytokine mRNA induction by interleukin-1beta or tumor necrosis factor alpha in vitro and in vivo.

Authors:  Ping Taishi; Lynn Churchill; Alok De; Ferenc Obal; James M Krueger
Journal:  Brain Res       Date:  2008-06-05       Impact factor: 3.252

8.  Sleep and Cytokines.

Authors:  Christopher J Davis; James M Krueger
Journal:  Sleep Med Clin       Date:  2012-09

9.  TNFalpha siRNA reduces brain TNF and EEG delta wave activity in rats.

Authors:  Ping Taishi; Lynn Churchill; Mingxiang Wang; Daniel Kay; Christopher J Davis; Xin Guan; Alok De; Tadanobu Yasuda; Fan Liao; James M Krueger
Journal:  Brain Res       Date:  2007-05-05       Impact factor: 3.252

Review 10.  Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.